Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cappelli

Showing results (81-90 of 196) with videos related to

Pageof 20
Sort By:
International Journal of Cardiology|April 18, 2021
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in TuscanyMattia Zampieri, Giulia Nardi, Guido Del Monaco, et al.
Giornale Italiano Di Cardiologia (2006)|September 28, 2023
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy]Alessia Argirò, Mattia Zampieri, Alberto Marchi, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 16, 2019
Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphyChiara Gallini, Francesca Tutino, Raffaele Martone, et al.
Journal of Hypertension|February 11, 2014
Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosisStefano Perlini, Francesco Salinaro, Francesco Musca, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 21, 2009
Echo/Doppler-derived time intervals are able to predict left ventricular reverse remodeling after cardiac resynchronization therapyCristina M Porciani, Alessio Lilli, Francesco Cappelli, et al.
European Journal of Human Genetics : EJHG|November 15, 2022
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central ItalyFrancesco Mazzarotto, Alessia Argirò, Mattia Zampieri, et al.
International Journal of Cardiology|January 6, 2022
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosisMattia Zampieri, Alessia Argirò, Marco Allinovi, et al.
Aging Clinical and Experimental Research|May 2, 2023
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosisCarlo Fumagalli, Martina Smorti, Lucia Ponti, et al.
Nature Communications|July 5, 2019
Fully phase-stabilized quantum cascade laser frequency combLuigi Consolino, Malik Nafa, Francesco Cappelli, et al.
Clinical Pharmacokinetics|May 27, 2026
Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR AmyloidosisMarianna Fontana, Vincent Algalarrondo, Pablo Garcia-Pavia, et al.
Pageof 20

Showing results (81-90 of 196) with videos related to

Sort By:
Pageof 20
International Journal of Cardiology|April 18, 2021
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in TuscanyMattia Zampieri, Giulia Nardi, Guido Del Monaco, et al.
Giornale Italiano Di Cardiologia (2006)|September 28, 2023
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy]Alessia Argirò, Mattia Zampieri, Alberto Marchi, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 16, 2019
Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphyChiara Gallini, Francesca Tutino, Raffaele Martone, et al.
Journal of Hypertension|February 11, 2014
Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosisStefano Perlini, Francesco Salinaro, Francesco Musca, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 21, 2009
Echo/Doppler-derived time intervals are able to predict left ventricular reverse remodeling after cardiac resynchronization therapyCristina M Porciani, Alessio Lilli, Francesco Cappelli, et al.
European Journal of Human Genetics : EJHG|November 15, 2022
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central ItalyFrancesco Mazzarotto, Alessia Argirò, Mattia Zampieri, et al.
International Journal of Cardiology|January 6, 2022
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosisMattia Zampieri, Alessia Argirò, Marco Allinovi, et al.
Aging Clinical and Experimental Research|May 2, 2023
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosisCarlo Fumagalli, Martina Smorti, Lucia Ponti, et al.
Nature Communications|July 5, 2019
Fully phase-stabilized quantum cascade laser frequency combLuigi Consolino, Malik Nafa, Francesco Cappelli, et al.
Clinical Pharmacokinetics|May 27, 2026
Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR AmyloidosisMarianna Fontana, Vincent Algalarrondo, Pablo Garcia-Pavia, et al.
Pageof 20